Gerasimov M R, Schiffer W K, Gardner E L, Marsteller D A, Lennon I C, Taylor S J, Brodie J D, Ashby C R, Dewey S L
Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
Eur J Pharmacol. 2001 Mar 2;414(2-3):205-9. doi: 10.1016/s0014-2999(01)00800-7.
Environments previously associated with drug use can become one of the most common factors triggering relapse to drug-seeking behavior. To better understand the neurochemical mechanisms potentially mediating these cues, we measured nucleus accumbens dopamine levels in animals exposed to environmental cues previously paired with cocaine administration. In animals exposed to a cocaine-paired environment nucleus accumbens dopamine increased by 25%. When administered 2.5 h prior to presentation of the environmental trigger, racemic vigabatrin (an irreversible inhibitor of gamma-aminobutyric acid (GABA)-transaminase) abolished this cue-induced increase. Conversely, R-(-)-vigabatrin, the inactive enantiomer, had no effect. Combined with our earlier findings, these studies support the potential therapeutic benefit of this enzyme-based GABAergic strategy to modulate brain dopamine and the subsequent treatment of drug addiction.
先前与药物使用相关的环境可能会成为触发寻求药物行为复发的最常见因素之一。为了更好地理解可能介导这些线索的神经化学机制,我们测量了暴露于先前与可卡因给药配对的环境线索的动物伏隔核中的多巴胺水平。在暴露于可卡因配对环境的动物中,伏隔核多巴胺增加了25%。当在呈现环境触发因素前2.5小时给予外消旋氨己烯酸(一种γ-氨基丁酸 (GABA) -转氨酶的不可逆抑制剂)时,消除了这种线索诱导的增加。相反,无活性对映体R-(-)-氨己烯酸没有效果。结合我们早期的研究结果,这些研究支持了这种基于酶的GABA能策略在调节脑多巴胺及后续治疗药物成瘾方面的潜在治疗益处。